Member Exclusive
NEWS ROUND-UP
Cell therapy weekly: FDA-approved CAR T-cell therapy to be covered by CMS
This week: World-first iPS cell clinical trial approved by Japan health ministry, new company raises funds to accelerate development of lifesaving cell therapies and Allogene Therapeutics to build state-of-the-art manufacturing facility for allogeneic CAR-T therapy development
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
- Connect and collaborate with other members
- Post about your own research, share your take on key topics and more
No comments yet.